Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Chronic Wounds, Ulcers, and Diabetic Ulcers
4.2.2 Increase in Volume of Surgical Procedures Worldwide
4.2.3 Growing Demand for Faster Recovery of Wounds
4.2.4 Increase in Aging Population
4.3 Market Restraints
4.3.1 Lack of Proper Reimbursements
4.3.2 High Treatment Costs
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Product
5.1.1 Wound Dressings
5.1.1.1 Film Dressings
5.1.1.2 Foams Dressings
5.1.1.3 Hydrogel Dressings
5.1.1.4 Collagen Dressings
5.1.1.5 Other Dressings
5.1.2 Active Wound Care
5.1.2.1 Skin Substitutes
5.1.2.2 Growth Factors
5.1.3 Therapy Devices
5.1.3.1 Negative Pressure Wound Therapy
5.1.3.2 Pressure Relief Devices
5.1.3.3 Hyperbaric Oxygen Equipment
5.1.3.4 Compression Therapy
5.1.3.5 Other Therapy Devices
5.1.4 Other Advance Wound Care Products
5.2 By Wound Type
5.2.1 Chronic Wound
5.2.1.1 Diabetic Foot Ulcer
5.2.1.2 Pressure Ulcer
5.2.1.3 Arterial and Venous Ulcer
5.2.1.4 Other Chronic Wound
5.2.2 Acute Wound
5.2.2.1 Surgical Wounds
5.2.2.2 Burns
5.2.2.3 Other Acute Wounds
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M Company
6.1.2 Organogenesis Holdings Inc.
6.1.3 B. Braun Melsungen AG
6.1.4 Cardinal Health, Inc
6.1.5 Coloplast A/S
6.1.6 ConvaTec Group Plc
6.1.7 Integra Lifesciences
6.1.8 Molnlycke Health Care
6.1.9 MiMedx Group, Inc.
6.1.10 Paul Hartmann AG
6.1.11 Smith & Nephew


7 MARKET OPPORTUNITIES AND FUTURE TRENDS